baber/WOPTO huggingface dataset:
Patent AT-E420385-T1 (AT)
Inventor: TIBERGHIEN HERVE
IPC: G02C5/14
Filed: 2001-07-02
Granted: 2009-01-15
Abstract: Eyeglasses have a vertical midplane of symmetry and comprise a front optical portion and two wire temples each associated with a respective side zone of the front optical portion. Each temple has a hinge end shaped as an eyelet lying in a vertical plane intersecting a general longitudinal direction of the temple. A hinge element is fixed on an inside surface of the corresponding side zone to receive the eyelet to pivot about an axis that is substantially normal to said inside surface, between a deployed position in which the temple is substantially perpendicular to the front optical portion, and a folded position in which the temple is substantially parallel to the front optical portion.
Patent AT-E293197-T1 (AT)
Inventor: BIENIEK JERZY MICHAL
IPC: E05B47/06
Filed: 2001-08-17
Granted: 2005-04-15
Abstract: The invention is in respect of a lock having a body and an actuator arrangement which is displaceable relative to the body between an inoperative condition and an operative condition. The actuator arrangement is capable of operating a device such as a locking mechanism or the like only when in its operative condition. The lock further includes non-mechanical key identification means. The lock further includes retaining means for retaining the actuator arrangement releasably in its inoperative condition. The retaining means is linked to the key identification means and operative in response to a signal received therefrom to permit displacement of the actuator arrangement to its operative condition. The actuator arrangement typically includes an inner member, an outer member and a coupling whereby the inner and outer member are coupled together to permit relative longitudinal displacement between the inner and outer member and inhibit relative rotational movement.
Patent AT-E328851-T1 (AT)
Inventor: ZIMMERMANN MICHAEL
IPC: A61L27/00
Filed: 2001-07-03
Granted: 2006-06-15
Abstract: Magnesium-ammonium phosphate cement formulation (A) comprises a powder mixture of molar amounts of calcium (Ca), magnesium (Mg) and orthophosphate (P) in the mixture in the proportions Ca/P between 1.00 and 1.50 and Mg/P between 0 and 0.50, an ammonium salt and water and/or an aqueous solution. Independent claims are also included for: (a) four Mg-ammonium phosphate cement formulations; and (b) the production of magnesium-ammonium phosphate cement from the formulations.
Patent AT-E353379-T1 (AT)
Inventor: RICHESON GALEN C
IPC: B01D39/00
Filed: 2001-08-22
Granted: 2007-02-15
Abstract: Embodiments of the present invention include a polypropylene homopolymer synthesized from a metallocene catalyst system and methods of forming the homopolymer, the homopolymer having an aluminum and chlorine recoverables value of less than 25 ppm and a xylene solubles of less than 1 wt % relative to the total weight of the homopolymer. The resulting homopolymer has other desirable properties such as a heat deflection temperature at 0.45 MPa of from 90° C. to 110° C., and a MWD value of from 1.7 to 5.0. These properties make embodiments of the homopolymer desirable for films, and in particular for capacitor films.
Patent AT-E284687-T1 (AT)
Inventor: MOLLY KOEN
IPC: A61K31/19
Filed: 2001-06-20
Granted: 2005-01-15
Abstract: The present invention relates to the use of one or more C6-C10 medium chain fatty acids (MCFA), salts, derivatives or mixtures or emulsions thereof for the inhibition of microbial contamination, growth and the subsequent toxin production. The MCFA are chosen from the group consisting of caproic (C6) acid, heptanoic (C7) acid, caprylic (C8) acid, nonanoic (C9) acid and capric (C10) acid. The invention further relates to a feed composition for an animal comprising a feed supplement containing one or more medium chain fatty acids (MCFA) chosen from the group consisting of caproic (C6) acid, heptanoic (C7) acid, caprylic (C8) acid, nonanoic (C9) acid and capric (C10) acid, preferably caprylic (C8) acid, and capric (C10) acid, salts, derivatives or mixtures or emulsions thereof.
Patent AT-E443971-T1 (AT)
Inventor: CHEN XUEMIN
IPC: H04N19/40
Filed: 2001-08-30
Granted: 2009-10-15
Abstract: A method and apparatus are disclosed by which a translucent logo is inserted into the transcoded digital bitstream of an MPEG transcoder without changing the digital nature of the bitstream. Such an MPEG transcoder has cascaded decoding and encoding sections. A translucent logo is generated and is added to the reconstructed video image produced by the decoder section of the MPEG transcoder upstream of the transcoder's encoding section. The encoding section of the transcoder then encodes the bitstream which includes the translucent logo.
Patent AT-E278152-T1 (AT)
Inventor: MORESCO PAOLO
IPC: F23D14/06
Filed: 2001-04-17
Granted: 2004-10-15
Abstract: Gas burner for a cooking hob, comprising a burner body provided with a plurality of openings for entry of primary air, a flame-dividing element which defines together with the burner body and air/gas mixing chamber, a gas injector which is mounted on the cooking hob, for injecting gas inside the mixing chamber, and a converging/diverging duct which defines a Venturi tube located downstream of the gas injector for drawing air into the mixing chamber. In accordance with the present invention, the burner body, the flame-dividing element and the converging/diverging duct consist of a single monolithic structure in the form of a pressed sheet-metal casing.
Patent AT-E329569-T1 (AT)
Inventor: CHUAH BENG S
IPC: A61K8/04
Filed: 2001-12-28
Granted: 2006-07-15
Abstract: Translucent anhydrous formulations containing particulate commercially available activated aluminium chlorohydrate (AACH) have a perceptible yellowness. The yellowness of translucent anhydrous compositions containing AACH can be ameliorated or eliminated whilst retaining the improved antiperspirant efficacy of AACH by controlling its water content to the range of 9 to 18%. The appearance of yellow formulations in or on a dispensing package, prior to application to the body, can appear to be neutralised to the human eye by employing a dispenser having a complementary colour in wall contacting the formulation, to promote achromicity. The complementary colour of the wall is dark green for yellow formulations.
Patent AT-E289900-T1 (AT)
Inventor: MOSS RICHARD J
IPC: B26D7/02
Filed: 2001-12-18
Granted: 2005-03-15
Abstract: An apparatus for supporting an elongated circular product during cutting includes a fixed lower support frame and a movable upper support frame. Right and left bottom support links include a lower end which is pivotally connected to the lower frame. Right and left side support links include a lower end which is slidably supported by a slot in the lower frame, an intermediate pivot point which is pivotally connected to the upper end of one of the bottom support links, and an upper end which is engageable with the product. The upper frame includes right and left guide surfaces which are engageable with the product. When the upper frame is moved downwardly toward the lower frame, the guide surfaces of the upper frame move the upper ends of the side support links closer to the center of the product.
Patent AT-E361060-T1 (AT)
Inventor: GORISSEN HENRICUS R M
IPC: A61K9/28
Filed: 2001-09-28
Granted: 2007-05-15
Abstract: The present invention is related to an optionally coated pharmaceutical hydrophilic gel forming matrix formulation comprising one or more active substances and having a prolonged release of said one or more active substances upon exposure to gastrointestinal fluids, characterized in that said release is substantially ion-strength independent. The invention is further related to a method of preparing this formulation which can be used in the administration of active substances for the treatment of a large number of disorders.
Patent AT-E402156-T1 (AT)
Inventor: MAUPIN GARY
IPC: A01N27/00
Filed: 2001-12-07
Granted: 2008-08-15
Abstract: Compounds, compositions, and methods for controlling an arthropod pest population that employ an eremophilane sesquiterpene parent structure are presented. The compounds have minimal adverse or toxic effects on humans, non-human animals, and the natural environment. The compounds may be isolated from natural sources, semi-synthesized from naturally occurring compounds, or completely synthesized. The compounds may be applied directly to a pest, or the locus of a pest, and function as topical or ingestible toxins. Eremophilane sesquiterpenes 13-hydroxy-valencene, valencene-11,12-epoxide, valencene-13-aldehyde, and nootkatone-1,10-11,12-diepoxide are exemplary compounds.
Patent AT-E340519-T1 (AT)
Inventor: PIJLS THOMAS FERDINAND ANNA
IPC: A23C3/037
Filed: 2001-12-21
Granted: 2006-10-15
Abstract: The invention relates to a method for preparing a product having a low content of microorganisms by using steam. A method according to the invention can be used to pasteurize or sterilize a product, while retaining the activity of one or more active substances that may be present in the product, and relates to a method wherein a product is dried with air. Furthermore, the invention relates to a product obtainable according to a method according to the invention.
Patent AT-E484758-T1 (AT)
Inventor: VAN DIGGELEN FRANK
IPC: G01S19/03
Filed: 2001-11-13
Granted: 2010-10-15
Abstract: A method for calculating position or time of a GPS receiver, a device, and a GPS receiver are provided, the method comprising: providing pseudoranges that estimate the range of the GPS receiver to a plurality of GPS satellites; providing an estimate of position of the GPS receiver; and computing absolute time using the pseudoranges and the position estimate.
Patent AT-E358076-T1 (AT)
Inventor: BORIANI SILVANO
IPC: B65D5/54
Filed: 2001-11-22
Granted: 2007-04-15
Abstract: A rigid cigarette packet ( 1 ), in the form of a right parallelepiped and extending along an axis (Z), has a container ( 4 ), and a lid ( 5 ) hinged to the container ( 4 ) along a hinge ( 6 ) so as to move between a closed position and an open position in which the lid ( 5 ) permits access to a compartment ( 14 ), housing cigarettes ( 2 ), through an opening ( 15 ) in the container ( 4 ), which has a front wall ( 9 ), a rear wall ( 10 ), two lateral walls ( 11 ), a bottom wall ( 12 ), and a top wall ( 13 ); the opening ( 15 ) extends along the front wall ( 9 ), between the hinge ( 6 ) on the front wall ( 9 ) and a free edge ( 18 ) of the front wall ( 9 ).
Patent AT-E280996-T1 (AT)
Inventor: TAKAYA MINORU
IPC: H01G4/30
Filed: 2002-02-22
Granted: 2004-11-15
Abstract: The invention is to offer electronic parts and a method of producing the same in which a producing time is shortened, crack or warp are hard to occur, and cost-down can be attained. Core substrates are made by forming a resin or a compound material made by mixing powder-like functional materials with this resin into thin plates, and hardening them. Conductor patterns are formed on at least any of front and back surfaces of the core substrates through any of an evaporation process, an ion plating process, an ion beam process, a sputtering process, and a vapor deposition process, followed by patterning. Half-hardened prepregs are produced by forming the resin or the compound material made by mixing powder-like functional materials with this resin into the thin plates. The prepregs and the core substrates are alternately laminated and laminated layers are made by unifying through a hot pressing. <IMAGE>
Patent AT-E350156-T1 (AT)
Inventor: WOEHRLE INGO DR
IPC: B01J31/32
Filed: 2002-08-19
Granted: 2007-01-15
Abstract: Carrier catalysts (I), useful in the preparation of cycloalkadiene by metathesis reaction, comprises a gamma -alumina as carrier material, rhenium oxide (1-12 wt.%), tin compound (II) or tin dioxide (0-40 wt.%) and at least one modifying agent of phosphorous, cesium or mineral acid. Carrier catalysts (I) useful in the preparation of cycloalkadiene by metathesis reaction, comprises a gamma -alumina as carrier material, rhenium oxide (1-12 wt.%), tin compound (II) of formula (SnR 4) or tin dioxide (0-40 wt.%) and at least one modifying agent of phosphorous, cesium or mineral acid. R 41-8C alkyl. An independent claim is included for the preparation of cycloalkadiene by metathesis reaction comprising reacting a cycloalka-mono-ene, a cyclopolyene and/or acyclic polyene in liquid phase, in the presence of (I).
Patent AT-E357285-T1 (AT)
Inventor: KAZ TILL
Filed: 2002-10-18
Granted: 2007-04-15
Abstract: A homogenizing device for a powder material comprises a homogenization chamber (33) filled with powder material, and a first rotor (38) and a second rotor (22) arranged a distance apart. The two rotors rotate in different directions to produce counter flows to comminute the powder material. <??>An Independent claim is also included for homogenizing a powder material. <??>Preferred Features: The rotors rotate at the same speed. A synchronization device (48) synchronizes a drive for the first rotor and a drive for the second rotor. The rotation axes (44, 46) of the rotors coincide.
Patent AT-E482968-T1 (AT)
Inventor: SCHWARZ SIGFRIED
IPC: A61K31/56
Filed: 1995-07-03
Granted: 2010-10-15
Abstract: 3-Sulphamoyloxy-oestra-1,3,5(10)-triene derivs. of formula (I) are new. R = NR1R2; R1, R2 = H or 1-5C alkyl; or NR1R2 = 4-6C polymethyleneimino or morpholino; R3 = H or 1-5C alkyl; R4 = H, opt. esterified OH, 1-5C haloalkyl or 1-5C alkoxy; R5, R6 = H; or R5+R6 = CH2; R7, R9 = H or OH; R8 = H, OH or 2-5C alkynyl; or R8+R9 = O or R5+R8 = CH=CH or CH2CH2; and the B ring opt. contains one or two double bonds.
Patent AT-E555807-T1 (AT)
Inventor: CASTILLO GERARDO
IPC: C07D311/62
Filed: 2002-03-15
Granted: 2012-05-15
Abstract: A method of treating an amyloid disease, or a disease characterized by alpha-synuclein or NAC fibrillogenesis, in a mammalian subject. The method includes administering to the mammal a therapeutically effective amount of a various disclosed catechins or green tea extract. A pharmaceutical composition comprising a therapeutically effective amount of a catechin and pharmaceutically acceptable excipient. The therapeutic amount of the catechin or green tea extracts is selected for efficacy in treating amyloid, alpha-synuclein or NAC fibrillogenesis in a mammalian subject.
Patent AT-E437193-T1 (AT)
Inventor: RICHTER FRANK
IPC: C07D251/34
Filed: 2002-05-07
Granted: 2009-08-15
Abstract: Production of polyisocyanates by catalytic conversion of aliphatic diisocyanates comprises using a catalyst consisting of a salt in which the anion comprises 5-97.1 wt.% of 1,2,3- and/or 1,2,4-triazolate structures.
Patent AT-E298675-T1 (AT)
Inventor: IMBERT LUCETTE
IPC: G01L5/00
Filed: 2002-04-08
Granted: 2005-07-15
Abstract: The invention relates to a device for fastening an electronic monitoring module onto a tire comprising a patch (12) of rubber mix, an upper surface of which bears at least one rigid insert (18, 19) having a threaded recess (181, 191) intended to cooperate with a screw (14, 15) and a lug (131, 132) on a casing (13) bearing the electronic monitoring module.
Patent AT-E388097-T1 (AT)
Inventor: HAAMER JOEL
IPC: B65D81/26
Filed: 2002-04-29
Granted: 2008-03-15
Abstract: A one-way valve, intended particularly for use in food packages The valve, which is intended to be fitted on a package, is arranged to open in response to an excess pressure inside and is recloseable. An adhesive sheet is arranged on top of an aperture formed in the packaging material. The adhesive sheet being arranged to uncover the aperture when exposed to pressure loads.
Patent AT-E383557-T1 (AT)
Inventor: MAK JOHN
IPC: F25J3/02
Filed: 2002-05-20
Granted: 2008-01-15
Abstract: A two-column NGL recovery plant includes an absorber (110) and a distillation column (140) in which the absorber (110) receives two cooled reflux streams, wherein one reflux stream (107) comprises a vapor portion of the NGL and wherein the other reflux stream (146) comprises a lean reflux provided by the overhead (144) of the distillation column (140). Contemplated configurations are especially advantageous in a upgrade of an existing NGL plant and typically exhibit C>3< recovery of at least 99% and C2 recovery of at least 90%.
Patent AT-E291644-T1 (AT)
Inventor: KNOTT WILFRIED
IPC: B22D21/04
Filed: 2002-05-25
Granted: 2005-04-15
Abstract: The invention relates to a process for producing metal/metal foam composite components, wherein a flat or shaped metal part is introduced into the cavity of a die, the cavity being at least partially delimited by the metal part, and then a mixture comprising a metal melt and a blowing agent which is solid at room temperature is introduced into the cavity, where it is foamed.
Patent AT-E307489-T1 (AT)
Inventor: ALTING AART CORNELIS
IPC: A23L27/60
Filed: 2002-07-31
Granted: 2005-11-15
Abstract: The present invention relates to a novel process for preparing a gelled aqueous composition, which process employs a gel-forming globular protein such as whey protein, ovalbumin or soy protein. More particularly the present invention concerns a process for preparing a product comprising a gelled aqueous composition, said composition containing at least 50 wt.% water, wherein the process comprises:   a. preparing an aqueous solution of a gel-forming globular protein comprising at least 3%, preferably at least 4.5% of the globular protein by weight of water; b. if necessary, adjusting the pH of the solution to at least 1 unit above the iso-clectric point of the globular protein; c. heating and/or pressurising said aqueous solution so as to obtain a suspension of aggregates of the globular protein, which aggregates have a number weighted average particle size in the range of 10-300 nanometers, preferably in the range of 15-200 nanometers; d. optionally, diluting the suspension to a concentration of at least 1% globular protein by weight of water e. inoculating the suspension with a micro-organism capable of acidifying the suspension; f. fermenting the suspension with the micro-organism so as to reduce the pH by at least 0.5 units to between 1 unit above and 1.5 units below the iso-electric point of the globular protein, preferably to between 0.8 units above and 1.0 unit below the iso-electric point.   The invention also relates to products obtainable by the above process.
Patent AT-E519436-T1 (AT)
Inventor: HUNT ROBERT
IPC: A61B18/12
Filed: 2002-06-25
Granted: 2011-08-15
Abstract: A multi-function laparoscopic instrument with an end effector assembly including at least first and second movable members, a first actuator coupled to the first movable member, a second actuator coupled to the second movable member, and a handle assembly. The handle assembly includes a drive mechanism, at least one movable trigger pivotably connected with the drive mechanism, and a switching mechanism coupled to the drive mechanism and having at least two positions, a first position in which the drive mechanism is engaged with the first actuator to operate the first movable member when the movable trigger is activated and, a second position in which the drive mechanism is engaged with the second actuator to operate the second movable member when the movable trigger is activated.
Patent AT-E445943-T1 (AT)
Inventor: KASHYAP VIVEK
IPC: G06F13/00
Filed: 2002-07-26
Granted: 2009-10-15
Abstract: The failover of nodes within networks, using a multicast address or a multicast port, is disclosed. A first node of a network joins a multicast group having a multicast address, which is assigned to the first node. Communication to the first node is achieved via communication to the multicast address, and/or through a multicast port on a switch of the network mapping to a port on the first node. When the first node fails, one of two actions occurs. First, a second node of the network may join the multicast group, such that the multicast address is assigned to the second node, and the second node handles communication to the multicast address. Second, the multicast port on the switch may be remapped to a port on the second node, so that communication to the multicast address is directed to the port on the second node.
Patent AT-E326249-T1 (AT)
Inventor: SEGAL ALAN JULIAN
IPC: A61M5/24
Filed: 2002-11-29
Granted: 2006-06-15
Abstract: A syringe has a barrel to receive a cartridge. The barrel has a front end portion to which a needle is connected for engagement with the cartridge. At its rear end, the barrel has a plunger mechanism. A sleeve is slidably mounted on the barrel and can be pushed forwards to sheath the needle. The needle is mounted on the barrel via a push-fit mounting device. The needle can be removed for disposal in a container by inserting the syringe into a tube on top of the container so that the protective needle sleeve is pushed back and the needle and mounting device pass through a collar of gripping fingers at an inner end of the tube. The fingers catch behind the mounting device so that this is pulled off to drop into the container with the needle when the syringe is withdrawn from the tube.
Patent AT-E305355-T1 (AT)
Inventor: AGARICO JOERG
IPC: B23D77/00
Filed: 2003-01-16
Granted: 2005-10-15
Abstract: The guide batten is used for grinding tools guided by a batten. The batten has a certain cobalt content, and this should be from 10 to over 21%, but always less than 35%. The grinding material used is polycrystalline diamond (PCD). Because of its cobalt content, the batten is easier to erode into the required shape.
Patent AT-E344266-T1 (AT)
Inventor: KRISTEN MARC OLIVER DR
IPC: C07C259/18
Filed: 2003-01-22
Granted: 2006-11-15
Abstract: Metal complexes of iminohydroxamic acids are new.  Metal complexes (I) of iminohydroxamic acids of formulae (1a) or (1b) are claimed. Nu  = O, S, NR4, PR4;  M  = Ti, Zr, Hf, V, Nb, Ta, Cr, Ni, Pd;  h = 0-4;  y = oxidation state of M minus 1; z=oxidation state of M minus 2;  X = halo, 1-6C alkoxy, acetylacetonate, (N(R5R6), 1-8C alkyl, 3-12C cycloalkyl, 7-13C aralkyl or 6-14C aryl;  R1, R4  =  H, optionally substitued 1-18C alkyl, optionally substittuted 2-18C alkenyl having 1-4 isolated or conjugated double bonds, optionally substituted 3-12C cycloalkyl, 7-13C aralkyl, 6-14C aryl optionally substituted with optionally substitiuted 1-18C alkyl or 2-18C alkenyl, 3-12C cycloalkyl, 7-13C aralkyl, 6-14C aryl, halo, optionally substituted 1-6C alkoxy, 6-14C aryloxy, SiR5R6R7, 5-6 membered nitrogen containing heteroaryl groups, optionally substituted with 1-18C alkyl or 2-18C alkenyl, 3-12C cycloalkyl, 7-13C aralkyl, 6-14C aryl, halo, 1-6C alkoxy, 6-14C aryloxy, SiR5R6R7;  R2 = optionally substituted 6-14C aryl or a 5-6 membered nitrogen containing heteroaryl, optionally substituted as above;  R3 = optionally substituted 1-18C alkyl, optionally substituted 2-18C alkenyl having 1-4 isolated or conjugated double bonds, optionally substituted 3-12C cycloalkyl, 7-13C aralkyl, optionally substituted 6-14C aryl, optionally substituted 5-6 membered nitrogen containing heteroaryl whereby neighboring R1-R4 groups are optionally bonded to form 5-12 membered rings optionally substituted by 1-8C alkyl or 2-8C alkenyl having 1-4 isolated or conjugated double bonds, 3-12C cycloalkyl, optionally substituted 7-13C aralkyl or 6-14C aryl;  L1 = (in)organic neutral ligand;  R5-R7  = H, 1-8C alkyl, 3-12C cycloalkyl, 7-13C aralkyl or 6-14C aryl Independent claims are included for: (i) a process for the (co)polymerization of olefins and/or styrene using the complexes (I); (ii) a process for the production of polyolefin waxes using the complexes (I) and a regulator, preferably hydrogen; (iii) a process for the production of the complexes (I) by deprotonation of a protonated ligand of formula (2) by means of a base followed by reaction with a metal compound of formula MXy+1 (3), optionally stabilized by neutral ligands; (iv) a process for the production of supported catalysts for the (co)polymerization of olefins by deposition of a complex (I) and optionally an activator onto a solid support; (v) the resulting supported catalyst; (vi) a process for the emulsion (co)polymerization of ethylene or other 1-olefins and optionally other olefins using the complex (I).